Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Isabella Strahan, daughter of "Good Morning America" co-anchor Michael Strahan, is opening up about her cancer journey in a new documentary.

Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.

Can pollution cause it? What about inflammation? And how do tumors spread? Here’s what scientists are learning about this complex disease.

Following surgery, radiotherapy and chemotherapy treatment at Addenbrooke's Hospital, Ms Webster has been described in medical circles as a cancer "super-survivor". In March, when she marks five years since her diagnosis,

Now aged two, Flynn, from Wigston in Leicestershire, went through months of chemotherapy and laser therapy to treat a rare type of eye cancer, called retinoblastoma Katie said the treatment was a "long road",

"Good Morning America" host Michael Strahan said it’s “hard to relive” Isabella’s cancer journey, which is documented in the Feb. 5 ABC special "Life Interrupted: Isabella Strahan’s Fight Against Canc

Young cancer patients have a 62% increased risk of dying if they live in a previously “redlined” residential area, researchers reported in a study published Jan. 27 in the journal Cancer. Even after adjusting for other factors, the risk of cancer death remains 32% higher among young people from redlined neighborhoods, researchers found.

The Mayo Clinic provides a perspective on 7 ways that individuals can reduce their risk: Eat healthier foods (thereby also reducing the consumption of processed foods) Maintain a healthy body weight and physical activity Prevent excessive sun exposure (to reduce the risk of skin cancer)

Medical advances mean many more people are surviving cancer and living for years or decades with its after effects. Here's how they are navigating life after treatment.

More than 13,000 women are diagnosed with the cancer each year, but those rates are dropping thanks to advances in preventative treatments and screenings

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost doubled – the cure rate for patients with the most common kind of breast cancer.